Should an International Deep Brain Stimulation (DBS) Patient Travel With a Companion?
Updated: 1 day ago

In brief
In most cases, yes. A trusted companion can help with medical history, medication timing, hospital communication, mobility, discharge instructions and the return journey.
For an international patient, Deep Brain Stimulation (DBS) is not limited to the operation itself. The journey may include neurological assessment, medication testing, imaging, surgery, wound review and initial programming. Even a patient who is independent at home may benefit from having someone present during this unfamiliar and demanding period.
Preparing for Deep Brain Stimulation (DBS) in Turkey
A companion can help collect medical records, confirm travel arrangements and prepare an accurate medication list. Parkinson's medicines should be carried in their original packaging and kept in hand luggage, together with enough supply for possible travel delays. It is helpful for both the patient and companion to know the dose times, particularly when crossing time zones.
The centre may request brain imaging, neurology reports, previous cognitive assessments and a short video showing movement during ON and OFF periods. A companion who sees the patient every day can help describe changes that are not always visible during a single video consultation.
Why does a companion matter?
Parkinson’s symptoms can fluctuate, and fatigue or anxiety may make it difficult to remember every detail. A companion can observe baseline function, bring medication on schedule and participate in discussions about realistic goals.
The companion often provides observations that are difficult to capture during a short examination: how long OFF periods last, whether falls occur at home and how dyskinesia affects daily activities. This information supports—but does not replace—the patient’s own priorities and consent.
The most useful companion is not necessarily the person with the strongest medical knowledge. It should be someone calm, reliable and able to listen, take notes and support the patient's decisions. The patient should remain at the centre of every discussion and should give consent personally whenever they have decision-making capacity.
During assessment and hospital care
DBS evaluations may contain a large amount of information: expected benefits, symptoms unlikely to improve, device options, surgical risks and the programming plan. A companion can write down questions and help the patient review the answers later. They can also describe the patient's usual walking, speech, sleep and independence more accurately than a brief clinic visit sometimes allows.
During admission, the companion can help maintain the usual medication schedule, but medicines should only be given according to the hospital team's instructions. Certain doses may deliberately be delayed or withheld for an examination or procedure. The companion should therefore communicate with the nursing and medical team rather than independently changing the schedule.
After surgery
The patient may need help with luggage, transport, wound observation and medication organization. A companion should know the centre’s contact details, warning signs and follow-up schedule. Their role is practical support—not making decisions instead of a capable patient.
Immediately after hospital discharge, tiredness, incision discomfort and changes in routine can make airports and transfers harder than expected. The companion can manage documents and communicate with the airline while the patient avoids lifting. Accessible accommodation, short transfer times and flexible tickets can reduce unnecessary strain.
The trip should include enough time for planned postoperative review. Flying home too early may make it difficult to assess wounds or respond to a new problem. Patients should ask the team for a medical summary, medication list, device information and clear instructions for their local doctor.
The companion should understand which findings require urgent contact: fever, increasing redness or drainage from an incision, wound opening, new weakness, seizure, confusion, a severe or unusual headache, or a sudden marked deterioration in Parkinson's symptoms. They should know which number to call both during working hours and in an emergency.
What help is useful after discharge?
Practical assistance is often more important than constant supervision. The patient may need help with transport, meals, medication organization, showering instructions and checking the scalp or chest incision. Heavy luggage should be handled by the companion. The patient should not be rushed through airports or asked to manage long transfers immediately after surgery.
A companion can also help prevent misunderstandings about the early result. DBS benefit is not always assessed immediately after implantation, and programming usually requires more than one visit. Temporary changes after surgery should not be interpreted as the final outcome of treatment.
Planning international travel
Confirm passport and visa requirements, travel insurance, airline assistance, medication documentation and accommodation accessibility. Carry medicines and the DBS identification card in hand luggage. The medical team should approve the date of return travel.
Accommodation should ideally have easy access, a lift and a bathroom that does not increase fall risk. If the patient uses a walking aid, requests wheelchair assistance or needs additional time at security, this should be arranged with the airline in advance. Flexible tickets are helpful because the return date may need to change for medical reasons.
Before leaving Türkiye, the patient and companion should have copies of the discharge summary, operative information, current medication plan, device details and follow-up schedule. It should also be clear who will provide programming after the patient returns home and how the local team can contact the DBS centre if necessary.
When might travelling alone be reasonable?
Travelling alone may be reasonable for some later programming visits if the patient is fully recovered, cognitively well, independently mobile and familiar with the journey. It is less suitable for the initial surgical trip, for patients with frequent OFF periods or falls, or when cognitive, speech or balance difficulties are present. The decision should be made individually with the treating team.
Frequently asked questions
Must the companion speak English or Turkish? It helps, but professional interpretation can be arranged.
Can I travel alone for programming later? Some patients can, once recovery is complete and the route is familiar; decide this individually.
Does the companion need to stay in the hospital overnight? Hospital policies differ. Even when an overnight stay is not possible, the companion should be reachable and available for discharge discussions.
How long should the companion remain in Turkey? This depends on the surgical pathway, wound review and programming schedule. Travel plans should not be finalized until the treating team has outlined the expected timeline.
Can a professional caregiver replace a family member? Sometimes. The caregiver must understand the patient's medication routine and the centre's instructions, while interpretation and informed-consent needs should be planned separately.
Conclusion
A companion adds safety, continuity and practical support throughout the DBS journey. For most international patients, travelling with a trusted person is strongly advisable for the assessment and surgical visit, even when the patient is normally independent at home.
Kaan Tugberk Ozdemir, MD
Neurosurgeon, Izmir, Turkey
General information only.
Send me your MRI for a review
If you recognise your symptoms in this article, send me your MRI scans and report on WhatsApp and I will review them personally. For more detail, see the Deep Brain Stimulation (DBS) page, or read how it works for UK patients.
Written by Kaan Tugberk Ozdemir, MD — Neurosurgeon | Izmir, Türkiye · Last updated: November 2026. This article is for general information and does not replace a consultation.
Sources:
Parkinson’s Foundation;
NHS travel guidance;
Device manufacturer travel guidance




Comments